News & Features

The world of MS information changes rapidly. Breakthroughs in understanding the mechanisms of MS, its cause, and its treatment come at a rapid pace. And there's so much to know just about managing the disease in your daily life! 

To keep you informed and up-to-date, MS Focus offers informative periodicals and round-the-clock multimedia broadcasting. Whether print or digital, these materials are designed to be easy to understand for MS patients, their families, and care providers. Subscriptions are free of charge.

Bristol Myers Squibb expands patient support programs

April 07, 2020

The program features immediate access for patients who have lost their employment and health insurance.
Learn more

iConquerMS seeks participants for COVID-19 study

April 03, 2020

The study is open to everyone, whether or not they have been diagnosed with, exposed to, or have symptoms of COVID-19.
Learn more

FDA approves Zeposia, a new oral treatment for relapsing MS

March 26, 2020

In clinical trials, Zeposia demonstrated efficacy on a key clinical marker of disease activity – annualized relapse rate – as compared to Avonex.
Learn more

A Message From Our Executive Director

March 19, 2020

A message from our Executive Director regarding COVID-19 (coronavirus) pandemic response.
Learn more

VR shows promise for early detection of MS balance problems

March 13, 2020

Researchers thought the MS subjects with balance impairments would differ clearly from normal subjects in these corrective reactions.
Learn more

Study: Diet has an effect on the MS disease course

March 12, 2020

Initial MRI studies showed propionic acid may reduce brain atrophy as a sign of neuronal cell death. 
Learn more

MS and coronavirus – What do you need to know?

March 06, 2020

If you have symptoms suspicious for COVID-19 infection, have traveled to a high risk area, or have been in close proximity to a person who meets one of those two criteria, please call your MS provider for further instructions.
Learn more

Molecule could improve brain function in patients with MS

February 28, 2020

Researchers found improvements in brain metabolism, particularly in areas that support cognition such as the frontal and temporal lobes in patients with MS.
Learn more

Study finds Spanish modified Story Memory Technique effective

February 21, 2020

The findings signal an important step toward culturally appropriate care for Spanish speakers with MS.
Learn more

Bristol Myers Squibb expands patient support programs

April 07, 2020

The program features immediate access for patients who have lost their employment and health insurance.
Learn more

iConquerMS seeks participants for COVID-19 study

April 03, 2020

The study is open to everyone, whether or not they have been diagnosed with, exposed to, or have symptoms of COVID-19.
Learn more

FDA approves Zeposia, a new oral treatment for relapsing MS

March 26, 2020

In clinical trials, Zeposia demonstrated efficacy on a key clinical marker of disease activity – annualized relapse rate – as compared to Avonex.
Learn more

A Message From Our Executive Director

March 19, 2020

A message from our Executive Director regarding COVID-19 (coronavirus) pandemic response.
Learn more

VR shows promise for early detection of MS balance problems

March 13, 2020

Researchers thought the MS subjects with balance impairments would differ clearly from normal subjects in these corrective reactions.
Learn more

Study: Diet has an effect on the MS disease course

March 12, 2020

Initial MRI studies showed propionic acid may reduce brain atrophy as a sign of neuronal cell death. 
Learn more

MS and coronavirus – What do you need to know?

March 06, 2020

If you have symptoms suspicious for COVID-19 infection, have traveled to a high risk area, or have been in close proximity to a person who meets one of those two criteria, please call your MS provider for further instructions.
Learn more

Molecule could improve brain function in patients with MS

February 28, 2020

Researchers found improvements in brain metabolism, particularly in areas that support cognition such as the frontal and temporal lobes in patients with MS.
Learn more

Study finds Spanish modified Story Memory Technique effective

February 21, 2020

The findings signal an important step toward culturally appropriate care for Spanish speakers with MS.
Learn more

Novartis seeking participants for EXCHANGE research study

February 18, 2020

The EXCHANGE study is looking at a medication for people who have advancing relapsing MS.
Learn more

Dietary interventions may slow onset of MS

February 12, 2020

Significantly reducing dietary levels of the amino acid methionine could slow onset and progression of MS in high-risk individuals.
Learn more

Study: ‘Priming’ molecule may be key to improved MS therapies

February 05, 2020

The findings could lead to more effective treatments for people living with MS.
Learn more

Scientist shows gene therapy protection of eyesight in models of MS

January 23, 2020

The study also shows how gene therapy may be used to preserve neural circuits and protect against vision loss in the disease.
Learn more

Researchers seek participants for relapsing MS study

January 17, 2020

The purpose of the research is to develop a report to inform supporters of patient education of the real-world needs of MS patients.
Learn more

Study explores factors affecting money management skills in MS

December 18, 2019

The association of money management difficulties with depressive symptomatology is a new finding, according to researchers.
Learn more

FDA approves first generics of Gilenya

December 11, 2019

The FDA approved three applications for first generics of Gilenya.
Learn more

Study suggests gut may be involved in MS development

December 06, 2019

The gut has long been suspected to play a role in MS; researchers have identified evidence of a potential mechanism.
Learn more

Study: Early lesions point to future secondary progressive MS

November 18, 2019

The findings suggest infratentorial lesions and deep white matter lesions at year one were the strongest early predictors of secondary progressive MS at 30 years.
Learn more


Show More News